These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6410 related articles for article (PubMed ID: 3021619)

  • 1. Lysis by natural killer cells requires viral replication and glycoprotein expression.
    Schattner A; Rager-Zisman B
    Immunol Lett; 1986 Oct; 13(5):261-8. PubMed ID: 3021619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
    Howell DM; Fitzgerald-Bocarsly P
    Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.
    Hale AH; Witte ON; Baltimore D; Eisen HN
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):970-4. PubMed ID: 204941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.
    Browning M; Reiss CS; Huang AS
    J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal.
    Fehr T; Bachmann MF; Bluethmann H; Kikutani H; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Mar; 168(2):184-92. PubMed ID: 8640864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenicity of persistently infected tumors in nude mice is a function of both virus and host cell type.
    VandePol SB; Holland JJ
    J Virol; 1986 Jun; 58(3):914-20. PubMed ID: 3009896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
    Puddington L; Bevan MJ; Rose JK; Lefrançois L
    J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus.
    Moller JR; Rager-Zisman B; Quan PC; Schattner A; Panush D; Rose JK; Bloom BR
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2456-9. PubMed ID: 2986117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 321.